Hepatitis C, ChronicNCT01457768
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
An observational study of Hepatitis C, Chronic, run by Gilead Sciences at 323 sites in 16 countries.
Trial summary
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hepatitis C, Chronic
- How many people
- 570 participants
- Where
- 323 sitesin 16 countries
- Study dates
- 19 Dec 2011to 9 Apr 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead OAV in a previous Gilead-sponsored HCV study.
Who may be able to join
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead OAV
- Have failed to achieve an SVR in a previous Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule
Who cannot join
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow-up, assessments or compliance with the protocol
- Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Trial locations and contacts
323 sites in 16 countries.
323 sites in 16 countries
United States158 sites
University of New Mexico
Albuquerque, New Mexico
Lehigh Valley Health Network, Network Office of Research and Innovation
Allentown, Pennsylvania, 18102
Lehigh Valley Health Network
Allentown, Pennsylvania
Advanced Clinical Research Institute, LLC
Anaheim, California, 92801
The North Texas Research Institute
Arlington, Texas, 76012
Texas Clinical Research Institute, LLC
Arlington, Texas
Asheville Gastroenterology Associates, P.A.
Asheville, North Carolina, 28801
Atlanta Gastroenterology Associates
Atlanta, Georgia, 30308
Emory University
Atlanta, Georgia, 30308
Digestive Healthcare of Georgia
Atlanta, Georgia, 30309
University of Colorado
Aurora, Colorado, 80045
Austin Hospital
Austin, Texas, 78704
Central Texas Clinical Research, LLC
Austin, Texas
Franco Felizarta, MD
Bakersfield, California, 93301
Mercy Medical Center
Baltimore, Maryland, 21202
Digestive Disease Associates, PA
Baltimore, Maryland, 21229
Johns Hopkins University
Baltimore, Maryland, 21287
Medical Development Centers, LLC
Baton Rouge, Louisiana, 70808
Gastroenterology Associates, LLC
Baton Rouge, Louisiana, 70809
Birmingham Gastroenterology Associates
Birmingham, Alabama, 35209
University of Alabama at Birmingham
Birmingham, Alabama, 35233
Massachusetts General Hospital
Boston, Massachusetts, 02114
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115
Community Research Initiative of New England
Boston, Massachusetts
Graves-Gilbert Clinic
Bowling Green, Kentucky, 42101
Pointe West Infectious Diseases d/b/a Bach and Godofsky Infectious Diseases
Bradenton, Florida, 34209
Lahey Clinic Medical Center
Burlington, Massachusetts, 01805
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
University of Chicago
Chicago, Illinois, 60637
Medical College of Wisconsin
Chicago, Illinois
Northwestern Memorial Hospital
Chicago, Illinois
Southern California Medical Group
Coronado, California, 92118
West Coast Clinical Trials, LLC
Costa Mesa, California, 92626
Nicholaos C. Bellos
Dallas, Texas, 75204
Baylor University Medical Center
Dallas, Texas, 75246
UT Southwestern Medical Center at Dallas
Dallas, Texas, 75390
Methodist Transplant Physicians
Dallas, Texas
UC Davis Medical Center
Davis, California, 95616
Infectious Disease Specialists of Atlanta
Decatur, Georgia, 30033
Henry Ford Health System
Detroit, Michigan, 48202
Digestive Health Specialists
Dothan, Alabama, 36305
Duke University Medical Center
Durham, North Carolina, 27710
South Denver Gastroenterology
Englewood, Colorado, 80113
Metropolitan Research
Fairfax, Virginia, 22031
Inova Fairfax Hospital Center for Liver Diseases
Falls Church, Virginia, 22042
Cumberland Research Associates, LLC
Fayetteville, North Carolina, 28304
University of Florida
Gainesville, Florida, 32610
Gastroenterology Center of the MidSouth, P.C.
Germantown, Tennessee, 38138
Memphis Gastroenterology Group
Germantown, Tennessee, 38138
Gastro One
Germantown, Tennessee
ID Care, Inc.
Hillsborough, New Jersey, 08844
Therapeutic Concepts, PA
Houston, Texas, 77004
Kelsey Research Foundation
Houston, Texas, 77005
Research Specialists of Texas
Houston, Texas, 77030
St. Luke's Episcopal Hospital
Houston, Texas, 77030
Baylor College of Medicine
Houston, Texas
St. Luke's Health Baylor College of Medicine Medical Center
Houston, Texas
Indianapolis Gastroenterology Research Foundation
Indianapolis, Indiana, 46237
Indiana University School of Medicine
Indianapolis, Indiana
Binghamton Gastroenterology Associates
Johnson City, New York, 13790
University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas, 66160
University of Kansas Medical Center
Kansas City, Kansas
Kansas City Gastroenterology and Hepatology
Kansas City, Missouri, 64131
Kaiser Permanente Institute for Health Research
La Jolla, California, 92037
Scripps Clinic
La Jolla, California, 92037
University of California San Diego
La Jolla, California, 92161
eStudySite
La Mesa, California, 91942
Regional Gastroenterology Associates of Lancaster, Ltd.
Lancaster, Pennsylvania, 17604
Impact Clinical Trials
Las Vegas, Nevada, 89106
VA Long Beach Healthcare System
Long Beach, California, 90822
Kaiser Permanente of Colorado
Los Angeles, California, 90027
Peter J. Ruane, MD, Inc.
Los Angeles, California, 90036
8631 West 3rd Street
Los Angeles, California, 90048
California Liver Institute
Los Angeles, California, 90048
Anthony Mills MD, Inc
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
Veterans Administration Wadsworth Medical Center
Los Angeles, California
Wisconsin Hospital and Clinic
Madison, Wisconsin, 53792
North Shore University Hospital
Manhasset, New York, 11030
Gastrointestinal Specialists of Georgia, PC
Marietta, Georgia, 30060
Schleinitz Research and Gastroenterology LLC
Medford, Oregon, 97504
University of Miami Miller School of Medicine
Miami, Florida
Research Center at Affiliates in Gastroenterology
Morristown, New Jersey, 07960
Nashville Medical Research Institute
Nashville, Tennessee, 37205
Nashville Gastrointestinal Specialists, Inc
Nashville, Tennessee, 37211
Quality Medical Research, PLLC
Nashville, Tennessee
Yale University School of Medicine
New Haven, Connecticut, 06520
Advanced Research Institute
New Port Richey, Florida, 34653
Concorde Medical Group PLLC
New York, New York, 10016
Weill Medical College of Cornell Univeristy
New York, New York, 10021
St. Luke's Roosevelt Hospital
New York, New York, 10025
Mount Sinai School of Medicine
New York, New York, 10029
Columbia University Medical Center
New York, New York, 10032
Mount Sinai Beth Israel
New York, New York
Saint Luke's-Roosevelt Hospital Center
New York, New York
Saint Michael's Medical Center
Newark, New Jersey, 07102
Saint Michael's Medical Center
Newark, New Jersey
Liver Institute of Virginia
Newport News, Virginia
Digestive and Liver Disease Specialists
Norfolk, Virginia, 23502
eStudySite
Oceanside, California, 92056
Orlando Immunology Center-
Orlando, Florida, 32803
Internal Medicine Specialists
Orlando, Florida, 32806
Orlando Clinical Research Center
Orlando, Florida, 32809
Stanford University
Palo Alto, California, 94304
660 South Fair Oaks Avenue
Pasadena, California, 91105
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Philadelphia FIGHT
Philadelphia, Pennsylvania, 19107
Philadelphia FIGHT
Philadelphia, Pennsylvania
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Mayo Clinic
Phoenix, Arizona
UPMC Center For Liver Diseases
Pittsburgh, Pennsylvania, 15213
Veterans Affairs Pittsburgh Healthcare System
Pittsburgh, Pennsylvania
Minnesota Gastroenterology, P.A.
Plymouth, Minnesota, 55446
Oregon Health & Science University
Portland, Oregon, 97239
The Miriam Hospital
Providence, Rhode Island, 02904
University Gastroenterology
Providence, Rhode Island, 02905
Liver Institute of Virginia, Bon Secours Health System
Richmond, Virginia, 23249
Virginia Commonwealth University Medical Center
Richmond, Virginia
200 1st st SW
Rochester, Minnesota, 55902
Mayo Clinic
Rochester, Minnesota
University of Rochester
Rochester, New York
UC Davis Medical Center
Sacramento, California, 95817
Minnesota Gastroenterology, P.A.
Saint Paul, Minnesota, 55114
Lifetree Clinical Research
Salt Lake City, Utah, 84106
University of Utah Pediatric Pulmonology
Salt Lake City, Utah, 84143
PRA Health Sciences
Salt Lake City, Utah
Alamo Medical Research
San Antonio, Texas, 78215
The Texas Liver Institute
San Antonio, Texas
University of California San Diego
San Diego, California, 92103
Research and Education, Inc.
San Diego, California, 92115
Medical Associates Research Group, Inc.
San Diego, California, 92123
California Pacific Medical Center
San Francisco, California, 94115
Quest Clinical Research
San Francisco, California, 94115
University of California, San Francisco School of Medicine
San Francisco, California, 94143
San Francisco General Hospital
San Francisco, California
University of California San Francisco
San Francisco, California
San Jose Gastroenterology
San Jose, California, 95116
Silicon Valley Research Institute
San Jose, California
Southwest C.A.R.E. Center
Santa Fe, New Mexico, 87505
Harborview Medical Center
Seattle, Washington
The Research Institute
Springfield, Massachusetts, 01105
Saint Louis University
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
St. Joseph's Comprehensive Research Institute
Tampa, Florida, 33614
Saint Joseph's Hospital
Tampa, Florida
Tampa General Hospital
Tampa, Florida
Los Angeles BioMedical Institute at Harbor-UCLA Medical Center
Torrance, California, 90502
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California
University of Arizona
Tucson, Arizona, 85724
Options Health Research LLC
Tulsa, Oklahoma, 74104
Digestive Health Specialists
Tupelo, Mississippi, 38801
The Gastroenterology Group of South Jersey
Vineland, New Jersey, 08360
Whitman Walker Clinic
Washington D.C., District of Columbia, 20009
Capital Medical Associates, P.C.
Washington D.C., District of Columbia, 20036
South Florida Center of Gastroenterology, P.A.
Wellington, Florida, 33414
Digestive Health Specialists, PA
Winston-Salem, North Carolina, 27103
Partners in Internal Medicine, PC
Worcester, Massachusetts, 01608
Westchester Medical Center
Yonkers, New York, 10701
Germany33 sites
Leber- and Studienzentrum am Checkpoint
Berlin, 10969
Charite Campus Virchow-Klinikum
Berlin, 13353
Seestrasse 13
Berlin, 13353
MIB Dienstleistung GmbH
Berlin
Universitätsklinikum Bonn
Bonn, 53105
Klinik für Gastroenterologie und Hepatologie am Abdominalzentrum
Cologne, North Rhine-Westphalia, 50937
Medizinisches Versorgungszentrum
Düsseldorf, North Rhine-Westphalia
Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia
Center for HIV and Hepatogastroenterology
Düsseldorf, 40237
Medizinisches Zentrum - Klinik für Gastroenterologie und Hepatologie
Essen, North Rhine-Westphalia, 45122
Klinikum der Johann Wolfgang Goethe Universitaet
Frankfurt, 60590
Klinikum der Johann Wolfgang-Goethe-Universität
Frankfurt
Universitätsklinikum Frankfurt
Frankfurt
Infektiologikum
Frankfurt am Main, Hesse
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse
Bertoldstrasse 48
Freiburg im Breisgau, Baden-Wurttemberg, 79098
Albert-Ludwigs-Universität
Freiburg im Breisgau, Baden-Wurttemberg
Medizinische Universitatsklinik
Freiburg im Breisgau, 79106
Asklepios Klinik St. Georg
Hamburg, 20099
Universitatsklinikum Hamburg-Eppendorf
Hamburg, 20246
Institut für interdisziplinäre Medizin Studien GmbH an der Asklepiosklinik Saint Georg
Hamburg
CRC Hannover
Hanover, Lower Saxony
Medizinische Hochschule Hannover
Hanover, 30625
Medizinische Universitätsklinik IV (Krehl Klinik) Abt. Gastroenterologie und Infektionskrankhen
Heidelberg, Baden-Wurttemberg
Klinikum der Universität Heidelberg
Heidelberg, 69120
Gastroenterologische Gemeinschaftspraxis
Herne, North Rhine-Westphalia
Gastroenterologische Gemeinschaftspraxis Kiel
Kiel, 24146
University of Leipzig
Leipzig, 04103
Johannes Gutenberg University Hospital
Mainz, 55131
Mainz University
Mainz
Klinikum Innenstadt der LMU Munchen
München, 81377
Universitätsklinik Würzburg
Wüerzburg
Universitätsklinikum Würzburg - Med Klinik und Poliklinik
Würzburg, 97080
France20 sites
Centre Hospitalier Universitaire de Grenoble
Cedex 9, Auvergne-Rhône-Alpes, 38043
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, Auvergne
Hopital Beaujon
Clichy, 92110
Hôpital Henri Mondor
Créteil, Île-de-France Region
Service des Maladies de l'Appareil Digestif et de la nutrition
Lille, Hauts-de-France, 59037
Hôpital Claude Huriez- Service d'Hépato-Gastroentérologie
Lille, Hauts-de-France
Hôpital-Saint Joseph, Service D'Hépato-Gastroentérologie
Marseille, Provence-Alpes-Côte d'Azur Region
Hopital Saint-Eloi
Montpellier, 34295
Hôpital de I´Archet 2
Nice, Provence-Alpes-Côte d'Azur Region
CHU de Nice - Hôpital l'Archet
Nice, 06202
Hôpital Saint Louis, Services des Maladies Infectieuses
Paris, 75010
Hopital Pitie-Salpetriere
Paris, 75013
Service Maladies Infectieuses
Paris, Île-de-France Region, 75012
Hôpital La Pitié Salpétrière, Service des Maladies Infectieuses
Paris, Île-de-France Region, 75651
Hôpital Bichat-Claude Bernard
Paris, Île-de-France Region, 75877
Hôpital Saint-Antoine
Paris, Île-de-France Region
Hôpital Haut-Lévêque, CHU Bordeaux
Pessac, Aquitaine
Hopital Pontchaillou
Rennes, 35033
C.H.U. Strasbourg - Hôpital Hautpierre - Hématologie
Strasbourg, 67091
CHU de Nancy
Vandœuvre-lès-Nancy, 54500
Australia19 sites
Flinders Medical Centre
Bedford Park, South Australia, 5042
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050
Canberra Specialist Centre
Canberra, Australian Capital Territory
102 Burton Street
Darlinghurst, New South Wales, 2010
East Sydney Doctors
Darlinghurst, New South Wales
St Vincent's Public Hospital Sydney
Darlinghurst, New South Wales
St Vincent's University Hospital
Fitzroy, 3065
Footscray Hospital
Footscray, Victoria
Austin Health
Heidelberg, Victoria
Liverpool Hospital
Liverpool, New South Wales, 2170
Alfred Hospital - Infectious Disease Unit
Melbourne, Victoria, 3004
Alfred Hospital
Melbourne, Victoria, 3004
Monash Medical Centre
Melbourne, Victoria, 3168
Fiona Stanley Hospital
Murdoch, Western Australia
Royal Perth Hospital
Perth, Western Australia, 6000
Royal Brisbane & Women's Hospital
QLD, 4029
Westmead Hospital
Westmead, New South Wales, 2145
Greenslopes Private Hospital
Woolloongabba, Queensland, 4102
Princess Alexandra Hospital
Woolloongabba, 4102
Italy16 sites
Azienda Ospedaliera Papa Giovanni XXIII
Bergamo, 24128
Azienda Ospedaliera di Bologna - Policlinico S. Orsola Malpighi
Bologna, 40138
Azienda Ospedaliera S. Orsola - Malpighi
Bologna
Ente Ospedaliero Ospedali Galliera di Genova
Genova
Ospedale San Raffaele-IRCCS, Centro San Luigi - San Raffaele Turro, Unità Operativa di Malattie Infettive
Milan, 20127
Azienda Ospedaliera
Milan, 20157
Dipartimento Polispecialistico - Malattie Infetive
Milan, 20162
Azienda Ospedaliera Ospedale Niguarda Ca' Granda
Milan
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan
Azienda Ospedaliera Padova, U.O.C. Cardiologia
Padova
Azienda Ospedaliera-universitaria Policlinico P. Giaccone
Palermo, 90127
Azienda Ospedaliero Universitaria di Parma
Parma
Malattie Infettive - Epatologia
Roma, 00149
Fondazione Policlinico Tor Vergata
Roma
Casa Sollievo della Sofferenza Hospital
San Giovanni Rotondo, Foggia, 71013
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino
Spain14 sites
Hospital Clinic I Provincial de Barcelona
Barcelona, 08036
Hospital Clinic I Provincial de Barcelona
Barcelona
Hospital General Universitario Gregorio Marañon
Madrid, 28007
Hospital Moncloa, Servicio de Enfermedades Infecciosas
Madrid, 28034
Hospital Universitario 12 de Octubre
Madrid, 28041
Hospital Universitario La Paz
Madrid, 28046
Paseo de la Castellana nº 261
Madrid, 28046
Hospital Universitario La Paz
Madrid
C / Manuel de Falla
Majadahonda, Madrid, 28222
Hospital Puerta de Hierro Majadahonda
Majadahonda, Madrid
Hospital Universitario Nuestra Señora de Valme
Seville, 41014
Hospital Universitario Nuestra Señora de Valme
Seville
Avenida Tres Cruces s/n
Valencia, 46018
Hospital General Universitario de Valencia
Valencia
United Kingdom13 sites
University of Birmingham and Queen Elizabeth Hospital Birmingham
Birmingham, England
Marlborough Street
Bristol, BS2 8HW
Southampton University Hospitals NHS Trust, Southampton General Hospital
Hampshire, England
Westminster Bridge Road
London, England, SE1 7EH
Chelsea and Westminster Hospital NHS Foundation Trust
London, England
Guy's and Saint Thomas NHS Foundation Trust
London, England
Imperial College Healthcare NHS Trust
London, England
King's College Hospital
London, England
St George Hospital
London, England
North Manchester General Hospital
Manchester, England
Queen's Medical Centre Campus
Nottingham, England, NG7 2UH
John Radcliffe Hospital
Oxford, England
Derriford Hospital
Plymouth, PL6 8DH
Canada12 sites
University of Calgary
Calgary, T2N 4Z6
University of Alberta
Edmonton, T6G2C8
Hopital Saint-Luc du CHUM
Montreal, H1T 2M4
Inspiration Research Limited
Toronto, Ontario
Toronto General Hospital
Toronto, M5G 2N2
Toronto Western Hospital
Toronto, M5T 2S8
Vancouver Infectious Disease Research and Care Centre
Vancouver, British Columbia
LAIR Centre
Vancouver, V5Z 1H2
Gordon & Leslie Diamond Health Care Centre
Vancouver, V5Z 1M9
University of British Colombia
Vancouver, V6Z 2C9
GIRI GI Research Institute
Vancouver, V6Z 2K5
University of Manitoba, Health Sciences Center
Winnipeg, R3E 3P4
Poland10 sites
Wojewódzki Szpital Specjalistyczny im. Kazimierza Dluskiego w Bialymstoku
Bialystok, Podlaskie Voivodeship
Szpital Specjalistyczny w Chorzowie
Chorzów, Silesian Voivodeship
SP ZOZ Wojewodzki Szpital Zakazny w Warszawie
Chorzów, 41-500
Wojewodzki Specjalistyczny Szpital im. W. Bieganskiego
Lodz, 91-347
ID Clinic
Mysłowice, Silesian Voivodeship
NZOZ Pol-SaNa-Med
Mysłowice, 41-400
Oddzial Dzienny
Warsaw, Masovian Voivodeship, 01-201
SP ZOZ Wojewódzki Szpital Zakazny
Warsaw, Masovian Voivodeship
Centrum Badan Klinicznych Osrodek Badan Wczesnej Fazy
Wroclaw, Lower Silesian Voivodeship
NZOZ Centrum Badan Klinicznych
Wroclaw, Lower Silesian Voivodeship
New Zealand9 sites
Christchurch Hospital
Christchurch, 8011
Auckland Clinical Studies Limited
Grafton, Auckland, 1010
Middlemore Hospital
Grafton, Auckland, 1010
Auckland City Hospital
Grafton, Auckland
Waikato Hospital (District Health Board)
Hamilton, 2001
Urosurgery
Hamilton
Wellington Hospital
Newton, WGN, 6021
Bay of Plenty Clinical School
Tauranga, Bay of Plenty
Wellington Hospital
Wellington
Sweden6 sites
Sahlgrenska Universitetssjukhuset, Östra sjukhuset
Gothenburg, Västra Götaland County
Sahlgrenska Universitetssjukhuset, Östra Sjukhus
Gothenburg, 41685
Skånes Universitetssjukhus
Lund, 22185
Skånes Universitetssjukhus i Lund
Lund
Skånes Universitetssjukhus, Malmö
Malmö
Karolinska Universitetssjukhuset Solna
Solna, 17176
Netherlands4 sites
Academisch Medisch Centrum
Amsterdam, North Holland
Leiden Universitair Medisch Centrum
Leiden, South Holland
Universitair Medisch Centrum Sint Radboud
Nijmegen
Erasmus Medisch Centrum
Rotterdam, South Holland
Puerto Rico3 sites
Chattanooga Hem/Oncology Ass (SCRI)
San Juan, PR, 00909
Clinical Research Puerto Rico
San Juan, PR
Fundacion De Investigacion De Diego
San Juan, 927
Austria2 sites
Medizinische Universität Graz
Graz, Styria
Wilhelminenspital der Stadt Wien
Vienna, State of Vienna
Czechia2 sites
Klinmed, s.r.o.
Prague, 16902
Remedis, s.r.o., Nestátní zdravotnické zarízení, Vladimírova 10
Prague
Estonia2 sites
West Tallinn Central Hospital
Talinn
Tartu University Hospital
Tartu
About this study
Official title: A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
- Conditions
- Hepatitis C, Chronic
- Keywords
- Hepatitis C, HCV, Sustained Virologic Response, Direct Acting Antiviral, Combination Therapy, Tegobuvir, Registry, HCV RNA, Treatment experienced, Treatment naive, GS 9451, GS 5885, Sequence, GS 5816, GS 7977, Sofosbuvir, Sovaldi™, SOF, Ledipasvir, LDV
- Medical subject headings
- Hepatitis C, Chronic, Hepatitis C
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of participants with at least one drug resistant mutation (DRM) loss from enrollment to end of study by treatment regimen
Measured: Up to 3 years
Secondary outcomes (4)
Proportion of participants with DRM loss by unit category, 1, 2, 3,…n, by treatment regimen
Measured: Up to 3 years
Average number of DRM loss by treatment regimen
Measured: Up to 3 years
Liver disease progression
Liver disease progression is a composite endpoint measured by laboratory parameters (alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin, albumin, platelets, prothrombin time (PT) and α-fetoprotein) and observed or reported clinical signs and symptoms.
Measured: Up to 3 years
Proportion of participants who develop hepatocellular carcinoma (HCC) through Week 144 by treatment regimen
Measured: Up to 144 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Oct 2011 (estimated)
- Study start19 Dec 2011
- Primary completion9 Apr 2018
- Study completion9 Apr 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Hepatitis C, ChronicStudies of the same condition, open and under way.
- More trials run by Gilead SciencesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 570 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gilead Sciences
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Gilead Study Director, Study director, Gilead Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01457768
- Sponsor's protocol ID
- GS-US-248-0123
- Other IDs
- 2011-000946-39
- Status last verified
- May 2018
- First submitted
- 4 Oct 2011
- Last updated
- 4 May 2018
- Results posted
- No
- Data monitoring committee
- No
Publications
Younossi ZM, Stepanova M, Racila A, Afendy A, Lawitz EJ, Schwabe C, Ruane PJ, Lalezari J, Reddy KR, Jacobson IM, Muir AJ, Gaggar A, Myers RP, Younossi I, Nader F. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection. Clin Gastroenterol Hepatol. 2020 Feb;18(2):468-476.e11. doi: 10.1016/j.cgh.2019.07.047. Epub 2019 Jul 31.
PubMed 31376493Younossi ZM, Stepanova M, Jacobson I, Muir AJ, Pol S, Zeuzem S, Younes Z, Herring R, Lawitz E, Younossi I, Racila A. Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes. Clin Infect Dis. 2020 Feb 3;70(4):628-632. doi: 10.1093/cid/ciz243.
PubMed 30949674
Study at a glance
From the registry record, last updated by the sponsor on 4 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
- ClinicalTrials.gov ID
- NCT01457768
- Acronym / sponsor ID
- GS-US-248-0123
- Conditions
- Hepatitis C, Chronic
- Keywords
- Hepatitis C, HCV, Sustained Virologic Response, Direct Acting Antiviral, Combination Therapy, Tegobuvir, Registry, HCV RNA
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 570 participants (actual)
- Lead sponsor
- Gilead SciencesIndustry (pharma, biotech, devices)
- Study start
- 19 Dec 2011 (actual)
- Primary completion
- 9 Apr 2018 (actual)
- Study completion
- 9 Apr 2018 (actual)
- First posted
- 24 Oct 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead OAV in a previous Gilead-sponsored HCV study.
Key inclusion criteria (4 listed)
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead OAV
- Have failed to achieve an SVR in a previous Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule
Key exclusion criteria (3 listed)
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow-up, assessments or compliance with the protocol
- Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Proportion of participants with at least one drug resistant mutation (DRM) loss from enrollment to end of study by treatment regimen
Time frame: Up to 3 years
4 secondary outcomes
Proportion of participants with DRM loss by unit category, 1, 2, 3,…n, by treatment regimen
Time frame: Up to 3 years
Average number of DRM loss by treatment regimen
Time frame: Up to 3 years
Liver disease progression
Time frame: Up to 3 years
Proportion of participants who develop hepatocellular carcinoma (HCC) through Week 144 by treatment regimen
Time frame: Up to 144 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 May 2018.
- Derived from this study: PubMed 31376493Younossi ZM, Stepanova M, Racila A, Afendy A, Lawitz EJ, Schwabe C, Ruane PJ, Lalezari J, Reddy KR, Jacobson IM, Muir AJ, Gaggar A, Myers RP, Younossi I, Nader F. Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection. Clin Gastroenterol Hepatol. 2020 Feb;18(2):468-476.e11. doi: 10.1016/j.cgh.2019.07.047. Epub 2019 Jul 31.
- Derived from this study: PubMed 30949674Younossi ZM, Stepanova M, Jacobson I, Muir AJ, Pol S, Zeuzem S, Younes Z, Herring R, Lawitz E, Younossi I, Racila A. Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes. Clin Infect Dis. 2020 Feb 3;70(4):628-632. doi: 10.1093/cid/ciz243.
Related trials for Hepatitis C, Chronic
RecruitingObservational study
Evaluation of Patients With Liver Disease
Hepatitis D, Hepatitis C
Active, not recruitingPhase 4
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Diabetes Mellitus, Hepatitis C, Chronic
RecruitingObservational study
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Chronic Liver Disease and Cirrhosis, Liver Cancer
Active, not recruitingPhase 4
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
Hepatitis C, Chronic, Pregnancy; Infection
Enrolling by invitationObservational study
Comparative Autoantibody and Immunologic Cell Marker Study
Autoimmune Diseases, Lupus Erythematosus, Systemic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gilead Study Director study director
Gilead Sciences
323 sites in 16 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hepatitis C, Chronic, run by Gilead Sciences at 323 sites in 16 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 323 sites in United States, Germany, France, Australia, Italy and 11 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of participants with at least one drug resistant mutation (DRM) loss from enrollment to end of study by treatment regimen (time frame: Up to 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01457768, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2018.